Wegovy’s most common side effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation, each affecting at least 5% of people in clinical trials. These tend to be worst during the first few months as your dose increases, and they usually improve over time. But digestive issues aren’t the full picture. Wegovy carries several less common but more serious risks worth understanding before and during treatment.
Why Wegovy Causes Digestive Problems
Wegovy (semaglutide) works by mimicking a hormone called GLP-1 that your gut naturally releases after eating. This hormone acts on three key areas: it triggers insulin release from the pancreas, activates fullness signals in the brain, and slows how quickly food leaves your stomach. That slowdown is a big part of why you feel less hungry on Wegovy, but it’s also the main reason for the nausea, vomiting, and bloating that so many people experience.
When food sits in your stomach longer than usual, it can create a persistent sense of fullness that tips into nausea, especially after larger or fattier meals. In some cases, this slowing becomes more extreme. The FDA has received reports of severe gastroparesis (near-paralysis of stomach movement) in people taking semaglutide, and intestinal blockage is listed as a potential side effect on the Wegovy label. These severe outcomes are rare, but they underscore that the digestive effects exist on a spectrum.
One practical consequence of delayed stomach emptying: if you need sedation for an endoscopy or surgery, food may still be sitting in your stomach even after standard fasting. A study found that 24% of patients on semaglutide had significant residual stomach contents before an upper endoscopy, compared to just 5% of patients not on the drug. If you have a procedure scheduled, let your care team know you’re taking Wegovy.
The Dose Escalation Schedule
Wegovy is designed to be started at a low dose and gradually increased over about four months specifically to reduce digestive side effects. The schedule looks like this:
- Weeks 1 through 4: 0.25 mg once weekly
- Weeks 5 through 8: 0.5 mg
- Weeks 9 through 12: 1 mg
- Weeks 13 through 16: 1.7 mg
- Week 17 onward: 1.7 mg or 2.4 mg (maintenance dose)
If a particular dose increase hits you hard, your prescriber can delay the next escalation by four weeks to give your body more time to adjust. Many people find that nausea peaks with each dose bump and then fades within a few weeks.
Gallbladder Problems
Rapid weight loss, from any cause, increases the risk of gallstones. Wegovy adds to that baseline risk. In adult clinical trials, 1.6% of people on Wegovy developed gallstones compared to 0.7% on placebo. Inflammation of the gallbladder (cholecystitis) occurred in 0.6% of Wegovy users versus 0.2% on placebo. In adolescents aged 12 and older, the rates were higher: 3.8% developed gallstones on Wegovy compared to zero on placebo.
Gallstone symptoms typically include sudden, intense pain in the upper right abdomen, sometimes radiating to the back or right shoulder, often after eating. If you experience this pattern, it warrants prompt evaluation.
Pancreatitis
Acute pancreatitis has been reported with Wegovy and other drugs in the same class, including rare fatal cases. In clinical trials, confirmed pancreatitis occurred in about 0.2% of Wegovy-treated patients per year, roughly double the rate in the placebo group. The hallmark symptom is severe, persistent abdominal pain, often radiating to the back, sometimes accompanied by nausea or vomiting. This is distinct from the general stomach discomfort that’s common on the drug. Pain that is intense, doesn’t let up, and feels deep rather than surface-level needs immediate medical attention.
Kidney Injury From Dehydration
Wegovy doesn’t directly damage the kidneys, but the vomiting and diarrhea it can cause may lead to severe dehydration, which in turn can trigger acute kidney injury. Some reported cases have been serious enough to require dialysis. The risk is highest when you’re first starting the medication or moving up to a higher dose, since that’s when GI side effects tend to be most intense. Staying well-hydrated is genuinely important on this medication, not just general wellness advice. If you’re vomiting repeatedly or having persistent diarrhea and can’t keep fluids down, that’s a situation that needs attention quickly.
Muscle Loss During Weight Loss
This side effect gets less attention than the GI symptoms, but it matters for long-term health. In the STEP 1 trial, people on semaglutide lost 43 to 45% of their total weight from lean muscle mass rather than fat. That’s a significantly higher proportion than what’s typical with diet alone, where lean mass usually accounts for 11 to 25% of weight lost. The ratio is closer to what’s seen after bariatric surgery.
Losing muscle matters because it lowers your resting metabolism, reduces physical function, and can make weight regain more likely. Resistance training and adequate protein intake are the primary strategies to preserve muscle while on Wegovy, and many obesity medicine specialists now emphasize these alongside the prescription.
Thyroid Tumor Warning
Wegovy carries a boxed warning, the most serious type, about thyroid C-cell tumors. In animal studies, semaglutide caused thyroid tumors (both benign and cancerous) at doses comparable to what humans take. Whether this translates to humans is unknown. Because of this uncertainty, Wegovy is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or a condition called MEN 2, which predisposes to thyroid cancer. There’s no recommended routine screening for thyroid tumors while on the drug, as existing tests aren’t reliable enough in this context and could lead to unnecessary procedures.
Injection Site Reactions
About 1.4% of Wegovy users in clinical trials experienced reactions at the injection site, including redness, itching, swelling, or irritation. This was only slightly higher than the 1% rate in the placebo group. Rotating your injection site between your abdomen, thigh, and upper arm can help minimize irritation.
Low Blood Sugar Risk
If you don’t have diabetes, Wegovy carries very little risk of low blood sugar on its own. The drug’s effect on insulin is glucose-dependent, meaning it primarily boosts insulin when blood sugar is already elevated. For people with type 2 diabetes, the picture changes. Combining Wegovy with insulin or certain diabetes medications (particularly sulfonylureas) can increase hypoglycemia risk, and those medications often need dose adjustments when Wegovy is started.
Mental Health Effects
Early on, Wegovy’s label included a warning about suicidal thoughts and behavior, which understandably concerned many people. The FDA has since requested that this warning be removed. A meta-analysis of 91 placebo-controlled trials covering nearly 108,000 patients found no increased risk of suicidal ideation or behavior with GLP-1 drugs. A separate large-scale study using health insurance claims data from over 2.2 million patients similarly found no elevated risk of intentional self-harm. The FDA’s conclusion: the totality of evidence does not support a causal link between these medications and suicidal thoughts or related psychiatric events like depression, anxiety, or psychosis.
Reducing Side Effects in Practice
Most of Wegovy’s common side effects respond to straightforward adjustments in how and what you eat. Smaller, more frequent meals reduce the burden on a stomach that’s emptying more slowly than usual. High-fat and high-sugar foods tend to worsen nausea, bloating, and diarrhea, while meals built around vegetables, lean protein, and whole grains are generally better tolerated. Smaller portions of high-fiber foods can also ease digestion without sacrificing nutrition.
Hydration deserves real attention, not just a passing mention. Water helps with both nausea and constipation, and it’s your main defense against the dehydration that can come from vomiting or diarrhea. If you’re struggling with constipation specifically, gradually increasing fiber and staying active both help. For most people, the first few months are the roughest stretch, and side effects become significantly more manageable once you’ve settled into your maintenance dose.